m+Medelevator.RU
← Поиск публикаций
Endocrine · 2026

Contemporary management of differentiated thyroid cancer in Latin America: results from the CaTaLiNA prospective multicenter registry.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Solis-Pazmino Paola, Pilatuna Eduardo A, Samaniego Alison Fernanda, Figueroa Luis A, Ledesma Tannya M, Pazmino-Chavez Camila N, Rojas Tatiana, Tite-Haro Maria B, Lincango Eddy P, Pazmino Nahomi, Escudero Kamila, Toro-Tobon David, Ponce-Ponte Oscar, Brito Juan P, CaTaLiNA, Paz-Ibarra José, Hernandez Victor, Salazar-Vega Jorge, Ruilova Lizbet, Garcia Cristhian, Imaicela Luis, Bonilla Francisco, Golbert Lenara, de Souza Meyer Erika Laurini, Otazu Magdalena, Gonzalez-Velazquez Camilo, Villagomez Mary, López Darlyng Patricia Quishpe, Avila Melanie Victoria Espin, Copa Diana Carolina Sosa, Herrera-Silvestre Hilder, Anicama-Pardo Ricardo, Somocurcio-Peralta José, León Paul Fernando Hurtado, Aray María Soledad Álvarez, Pesantez Maria Isabel Leon, Corral Raúl Francisco Adolfo Alvarado, Cayambe Jessica

Аннотация

BACKGROUND: International guidelines increasingly endorse treatment de-escalation for selected patients with differentiated thyroid cancer (DTC), including thyroid lobectomy and selective use of radioactive iodine (RAI) therapy. How contemporary clinical practice in Latin America aligns with these recommendations remains unclear. We evaluated contemporary management patterns and early outcomes within a large prospective regional registry.

METHODS: The Cancer de Tiroides en Latinoamerica (CaTaLiNA) registry is an international, prospective cohort study including patients treated at 11 centers across Ecuador, Peru, Mexico, Brazil, and Uruguay. Adult patients with histologically confirmed DTC undergoing initial thyroid surgery between June 1, 2023, and October 31, 2025, were analyzed. American Thyroid Association (ATA) 2015 risk of structural recurrence and AJCC 8th edition staging were assigned retrospectively. Primary outcomes were the extent of initial surgery, RAI utilization across the ATA risk categories, and early postoperative complications. Multivariable mixed-effects logistic regression was performed to identify factors associated with RAI use and postoperative complications.

RESULTS: A total of 901 patients were included (mean age 47.7 ± 13.3 years; 84.9% women). Papillary thyroid carcinoma accounted for 96.7% of cases. Most patients had early-stage disease (AJCC stage I, 81.5%). Total thyroidectomy was performed in 96.4% of patients. RAI was administered in 54.3% of patients, increasing across risk categories (40.7% low risk, 69.2% intermediate risk, and 59.6% high risk; p < 0.001). Tumor size, resection margin status, and a higher ATA 2015 risk category were independently associated with RAI use. Postoperative complications occurred in 15.4% of patients, predominantly transient hypocalcemia, and were more frequent in higher-risk groups; tumor size was the only independent predictor after adjustment.

CONCLUSIONS: In this large Latin American cohort, management of DTC frequently exceeded the intensity recommended by ATA guidelines, with high rates of total thyroidectomy and RAI, including among low-risk patients. The ATA 2015 framework enables more refined risk stratification; however, its integration into clinical practice remains incomplete. These findings provide important region-specific data and highlight opportunities to optimize risk-adapted care and reduce overtreatment in DTC.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты